Study VanDeVijver-ER-neg
Study informations
122 subnetworks in total page | file
1481 genes associated page | file
Enriched GO terms page
General informations
General Index page
Study Index page
Subnetwork 1126
score
| Dataset | Score | P-val 1 | P-val 2 | P-val 3 | Fisher Score |
|---|
| Desmedt | 0.3325 | 1.566e-03 | 2.800e-05 | 1.650e-01 | 7.236e-09 |
|---|
| IPC | 0.3406 | 3.491e-01 | 1.787e-01 | 9.357e-01 | 5.837e-02 |
|---|
| Loi | 0.4735 | 6.300e-05 | 0.000e+00 | 5.491e-02 | 0.000e+00 |
|---|
| Schmidt | 0.5994 | 1.000e-06 | 0.000e+00 | 1.139e-01 | 0.000e+00 |
|---|
| Wang | 0.2579 | 7.459e-03 | 6.531e-02 | 2.273e-01 | 1.107e-04 |
|---|
Expression data for subnetwork 1126 in each dataset
Desmedt |
IPC |
Loi |
Schmidt |
Wang |
Subnetwork structure for each dataset
- Desmedt
Score for each gene in subnetwork 1126 in each dataset
| Gene Symbol | Links | Frequency | Frequency Rank | Subnetwork score rank | Global rank |
Desmedt | IPC | Loi | Schmidt | Wang |
|---|
| EP300 |   | 71 | 3 | 1 | 2 | 0.016 | -0.149 | 0.087 | 0.102 | 0.025 |
|---|
| TEK | | 7 | 100 | 148 | 155 | 0.063 | -0.149 | -0.049 | 0.174 | 0.113 |
|---|
| CCNE2 | | 8 | 84 | 536 | 515 | -0.123 | 0.136 | -0.178 | 0.241 | -0.055 |
|---|
| C10orf2 | | 1 | 652 | 910 | 919 | -0.267 | 0.007 | 0.040 | 0.228 | -0.028 |
|---|
| NPR2 | | 1 | 652 | 910 | 919 | 0.006 | -0.163 | 0.120 | 0.211 | -0.003 |
|---|
| SUMO2 | | 12 | 55 | 148 | 150 | 0.003 | 0.117 | 0.062 | 0.294 | -0.096 |
|---|
| NAIP | | 1 | 652 | 910 | 919 | 0.133 | 0.070 | 0.240 | -0.047 | 0.037 |
|---|
| PSEN1 | | 5 | 148 | 847 | 821 | undef | -0.041 | 0.110 | undef | undef |
|---|
| EIF1B | | 6 | 120 | 57 | 62 | 0.029 | 0.149 | 0.075 | 0.332 | -0.070 |
|---|
| CALR | | 10 | 67 | 117 | 121 | -0.216 | -0.105 | 0.002 | -0.061 | -0.075 |
|---|
| NPR3 | | 1 | 652 | 910 | 919 | 0.115 | 0.016 | 0.005 | 0.195 | 0.034 |
|---|
| CDC42 | | 44 | 9 | 1 | 6 | 0.036 | 0.047 | 0.242 | -0.027 | -0.042 |
|---|
| CDH1 | | 54 | 5 | 1 | 4 | 0.211 | -0.227 | 0.187 | -0.236 | -0.024 |
|---|
| CTNNB1 | | 33 | 14 | 33 | 29 | 0.202 | -0.113 | 0.187 | 0.159 | 0.239 |
|---|
| TACC2 | | 9 | 77 | 148 | 154 | -0.151 | -0.073 | 0.122 | 0.181 | 0.180 |
|---|
| PIN1 | | 17 | 30 | 1 | 13 | 0.135 | 0.194 | 0.040 | -0.040 | -0.048 |
|---|
| RBM6 | | 10 | 67 | 148 | 152 | -0.036 | -0.082 | 0.265 | -0.004 | 0.111 |
|---|
| COBRA1 | | 4 | 198 | 206 | 205 | 0.150 | 0.137 | 0.335 | 0.159 | -0.016 |
|---|
| DLGAP1 | | 2 | 391 | 910 | 899 | -0.104 | 0.103 | 0.078 | 0.102 | -0.159 |
|---|
| RPL35 | | 5 | 148 | 57 | 63 | 0.114 | 0.108 | -0.012 | 0.370 | -0.220 |
|---|
| POLR2L | | 3 | 265 | 57 | 71 | -0.038 | 0.037 | -0.012 | 0.224 | 0.015 |
|---|
| ZC4H2 | | 16 | 34 | 339 | 332 | -0.145 | 0.065 | 0.061 | 0.304 | 0.059 |
|---|
| CASP9 | | 1 | 652 | 910 | 919 | -0.152 | -0.086 | 0.140 | -0.193 | -0.122 |
|---|
| PIK3R1 | | 91 | 1 | 1 | 1 | 0.189 | -0.237 | 0.381 | 0.065 | -0.002 |
|---|
| ECT2 | | 2 | 391 | 910 | 899 | -0.195 | 0.223 | -0.045 | 0.040 | -0.058 |
|---|
| NPR1 | | 1 | 652 | 910 | 919 | -0.084 | -0.259 | -0.122 | 0.191 | -0.180 |
|---|
| ILK | | 6 | 120 | 33 | 40 | 0.069 | -0.020 | 0.195 | 0.076 | 0.086 |
|---|
| VEGFA | | 28 | 15 | 57 | 49 | -0.074 | 0.090 | 0.200 | 0.030 | 0.148 |
|---|
| IMP3 | | 2 | 391 | 283 | 301 | 0.021 | 0.042 | -0.132 | 0.113 | -0.196 |
|---|
| FOS | | 20 | 24 | 148 | 138 | 0.060 | -0.137 | 0.129 | 0.185 | 0.234 |
|---|
| TCF7L2 | | 17 | 30 | 271 | 264 | -0.071 | -0.021 | 0.143 | 0.280 | 0.101 |
|---|
| POLR2A | | 5 | 148 | 271 | 267 | 0.019 | -0.107 | 0.247 | 0.091 | 0.141 |
|---|
| EGFR | | 72 | 2 | 117 | 117 | 0.064 | -0.195 | 0.240 | -0.205 | 0.065 |
|---|
| SOCS3 | | 3 | 265 | 492 | 503 | 0.180 | 0.201 | -0.110 | 0.064 | -0.138 |
|---|
| TPR | | 10 | 67 | 148 | 152 | 0.118 | -0.130 | 0.120 | -0.036 | 0.156 |
|---|
| CXCR4 | | 1 | 652 | 910 | 919 | -0.160 | -0.103 | -0.189 | -0.094 | -0.010 |
|---|
| INSR | | 47 | 7 | 1 | 5 | 0.135 | 0.063 | 0.173 | 0.135 | -0.072 |
|---|
| POLR2E | | 4 | 198 | 598 | 577 | 0.095 | 0.127 | 0.039 | 0.166 | -0.018 |
|---|
| TUBB2B | | 5 | 148 | 148 | 161 | 0.048 | -0.036 | 0.304 | 0.045 | 0.139 |
|---|
| TIE1 | | 6 | 120 | 148 | 156 | 0.094 | -0.108 | 0.005 | 0.141 | 0.252 |
|---|
| FGB | | 3 | 265 | 910 | 895 | -0.100 | 0.136 | 0.231 | -0.035 | -0.016 |
|---|
| LPL | | 4 | 198 | 584 | 571 | 0.013 | -0.102 | -0.062 | 0.292 | -0.105 |
|---|
| POLR2H | | 2 | 391 | 57 | 80 | -0.150 | 0.255 | -0.016 | 0.147 | 0.108 |
|---|
| GNA13 | | 3 | 265 | 910 | 895 | -0.103 | 0.109 | -0.208 | 0.108 | -0.092 |
|---|
| NCSTN | | 1 | 652 | 910 | 919 | -0.002 | 0.006 | 0.180 | -0.185 | -0.082 |
|---|
| MTCH1 | | 1 | 652 | 910 | 919 | -0.141 | 0.015 | -0.091 | 0.197 | 0.195 |
|---|
GO Enrichment output for subnetwork 1126 in each dataset
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| nuclear migration | GO:0007097 |  | 1.102E-06 | 2.534E-03 |
|---|
| positive regulation of pseudopodium assembly | GO:0031274 | | 1.102E-06 | 1.267E-03 |
|---|
| macrophage differentiation | GO:0030225 | | 2.195E-06 | 1.683E-03 |
|---|
| RNA elongation from RNA polymerase II promoter | GO:0006368 | | 3.152E-06 | 1.812E-03 |
|---|
| regulation of lipid kinase activity | GO:0043550 | | 3.828E-06 | 1.761E-03 |
|---|
| establishment of nucleus localization | GO:0040023 | | 3.828E-06 | 1.468E-03 |
|---|
| RNA elongation | GO:0006354 | | 3.888E-06 | 1.278E-03 |
|---|
| Wnt receptor signaling pathway through beta-catenin | GO:0060070 | | 6.104E-06 | 1.755E-03 |
|---|
| regulation of vascular permeability | GO:0043114 | | 6.104E-06 | 1.56E-03 |
|---|
| nucleus localization | GO:0051647 | | 9.124E-06 | 2.098E-03 |
|---|
| regulation of cell projection assembly | GO:0060491 | | 1.299E-05 | 2.716E-03 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| Wnt receptor signaling pathway through beta-catenin | GO:0060070 | | 2.443E-10 | 5.968E-07 |
|---|
| Notch receptor processing | GO:0007220 | | 4.431E-07 | 5.413E-04 |
|---|
| myoblast cell fate commitment | GO:0048625 | | 8.84E-07 | 7.198E-04 |
|---|
| nuclear migration | GO:0007097 | | 8.84E-07 | 5.399E-04 |
|---|
| positive regulation of pseudopodium assembly | GO:0031274 | | 8.84E-07 | 4.319E-04 |
|---|
| RNA elongation from RNA polymerase II promoter | GO:0006368 | | 1.222E-06 | 4.976E-04 |
|---|
| amyloid precursor protein catabolic process | GO:0042987 | | 1.543E-06 | 5.385E-04 |
|---|
| RNA elongation | GO:0006354 | | 1.776E-06 | 5.423E-04 |
|---|
| regulation of lipid kinase activity | GO:0043550 | | 2.462E-06 | 6.683E-04 |
|---|
| positive regulation of insulin secretion | GO:0032024 | | 2.462E-06 | 6.015E-04 |
|---|
| regulation of vascular permeability | GO:0043114 | | 2.462E-06 | 5.468E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| Wnt receptor signaling pathway through beta-catenin | GO:0060070 | | 1.542E-10 | 3.71E-07 |
|---|
| Notch receptor processing | GO:0007220 | | 4.846E-07 | 5.83E-04 |
|---|
| myoblast cell fate commitment | GO:0048625 | | 9.667E-07 | 7.753E-04 |
|---|
| nuclear migration | GO:0007097 | | 9.667E-07 | 5.814E-04 |
|---|
| positive regulation of pseudopodium assembly | GO:0031274 | | 9.667E-07 | 4.652E-04 |
|---|
| RNA elongation from RNA polymerase II promoter | GO:0006368 | | 1.274E-06 | 5.11E-04 |
|---|
| regulation of lipid kinase activity | GO:0043550 | | 1.687E-06 | 5.799E-04 |
|---|
| amyloid precursor protein catabolic process | GO:0042987 | | 1.687E-06 | 5.074E-04 |
|---|
| macrophage differentiation | GO:0030225 | | 1.687E-06 | 4.51E-04 |
|---|
| RNA elongation | GO:0006354 | | 1.865E-06 | 4.488E-04 |
|---|
| positive regulation of insulin secretion | GO:0032024 | | 2.692E-06 | 5.888E-04 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| nuclear migration | GO:0007097 | | 1.102E-06 | 2.534E-03 |
|---|
| positive regulation of pseudopodium assembly | GO:0031274 | | 1.102E-06 | 1.267E-03 |
|---|
| macrophage differentiation | GO:0030225 | | 2.195E-06 | 1.683E-03 |
|---|
| RNA elongation from RNA polymerase II promoter | GO:0006368 | | 3.152E-06 | 1.812E-03 |
|---|
| regulation of lipid kinase activity | GO:0043550 | | 3.828E-06 | 1.761E-03 |
|---|
| establishment of nucleus localization | GO:0040023 | | 3.828E-06 | 1.468E-03 |
|---|
| RNA elongation | GO:0006354 | | 3.888E-06 | 1.278E-03 |
|---|
| Wnt receptor signaling pathway through beta-catenin | GO:0060070 | | 6.104E-06 | 1.755E-03 |
|---|
| regulation of vascular permeability | GO:0043114 | | 6.104E-06 | 1.56E-03 |
|---|
| nucleus localization | GO:0051647 | | 9.124E-06 | 2.098E-03 |
|---|
| regulation of cell projection assembly | GO:0060491 | | 1.299E-05 | 2.716E-03 |
|---|
| Name | Accession Number | Link | P-val | Corrected P-val |
|---|
| nuclear migration | GO:0007097 | | 1.102E-06 | 2.534E-03 |
|---|
| positive regulation of pseudopodium assembly | GO:0031274 | | 1.102E-06 | 1.267E-03 |
|---|
| macrophage differentiation | GO:0030225 | | 2.195E-06 | 1.683E-03 |
|---|
| RNA elongation from RNA polymerase II promoter | GO:0006368 | | 3.152E-06 | 1.812E-03 |
|---|
| regulation of lipid kinase activity | GO:0043550 | | 3.828E-06 | 1.761E-03 |
|---|
| establishment of nucleus localization | GO:0040023 | | 3.828E-06 | 1.468E-03 |
|---|
| RNA elongation | GO:0006354 | | 3.888E-06 | 1.278E-03 |
|---|
| Wnt receptor signaling pathway through beta-catenin | GO:0060070 | | 6.104E-06 | 1.755E-03 |
|---|
| regulation of vascular permeability | GO:0043114 | | 6.104E-06 | 1.56E-03 |
|---|
| nucleus localization | GO:0051647 | | 9.124E-06 | 2.098E-03 |
|---|
| regulation of cell projection assembly | GO:0060491 | | 1.299E-05 | 2.716E-03 |
|---|
